Direct-to-consumer blood testing

Last updated

Direct-to-consumer blood testing (DTC blood testing), also known as direct access testing (DAT), is a form of laboratory testing that allows consumers to order blood tests directly from a clinical laboratory without requiring a prescription or referral from a physician. [1] This market has grown significantly in recent years, driven by consumer interest in personalized health management, advances in laboratory technology, and regulatory changes that have expanded access in many jurisdictions. [2]

Contents

These services typically offer comprehensive metabolic panels, lipid profiles, hormone testing, nutritional markers, and increasingly sophisticated biomarker assessments that were traditionally only available through healthcare providers. [3] Over the last decade, a paradigm shift has taken place with consumers seeking greater involvement in decisions affecting their healthcare and with policies that enable this involvement. [1]

Market overview and analysis

Industry growth

The global blood testing market was valued at approximately USD 96.62 billion in 2024 and is projected to reach USD 160.50 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.83%. [4] The DTC segment represents a rapidly growing portion of this market, fueled by increasing consumer health awareness and technological innovations in sample collection and analysis. [5]

North America dominates the market with the largest revenue share (approximately 44.83% in 2024), driven by well-established healthcare infrastructure, favorable regulatory environments in many states, and high consumer acceptance of self-directed healthcare services. [4]

Key market drivers

Regulatory landscape

Federal regulation

Laboratory testing in the United States is subject to federal regulation. Clinical laboratories performing testing are overseen by the Centers for Medicare and Medicaid Services (CMS) utilizing national standards established under the Clinical Laboratory Improvement Amendments (CLIA). [1] The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) assist CMS in this process. [7]

Clinical Laboratory Improvement Amendments (CLIA)

CMS ensures the integrity of laboratories performing testing via inspections and consistent oversight, bolstered with proficiency testing by accredited organizations. CLIA authorizes regulation of laboratories that conduct testing, not the individuals who order the tests or receive test results. [8] All laboratories performing DTC testing must obtain CLIA certification and maintain compliance with national standards. [8]

Food and Drug Administration (FDA)

The FDA reviews commercially available test kits and their associated medical claims to ensure safety and efficacy before products are cleared or approved for use. The regulatory landscape for laboratory developed tests (LDTs) has been evolving significantly. [7]

On May 6, 2024, the FDA issued a final rule significantly modifying its approach to oversight of laboratory-developed tests, amending regulations to clarify that in vitro diagnostic products (IVDs) are devices under the Federal Food, Drug, and Cosmetic Act, including when manufactured by a laboratory. [9] The final rule includes a policy under which FDA would phase out enforcement discretion for LDTs over a four-year period. [10]

The phaseout policy consists of five stages, starting May 6, 2024. DTC tests are specifically noted as having never been subject to enforcement discretion, meaning compliance with FDA requirements has always been expected for consumer-facing diagnostic tests. [11]

However, on April 17, 2025, a federal court blocked FDA's final rule on LDTs, creating uncertainty about the regulatory future. [12] LDTs continue to be governed by CMS under CLIA oversight, but the long-term regulatory framework remains unsettled. [12]

Federal Trade Commission (FTC)

The Federal Trade Commission monitors the DTC testing market for deceptive marketing strategies and unsubstantiated claims, taking action against companies that make misleading representations about test accuracy, interpretation, or health benefits. [2]

State-level regulation

State laws significantly influence the availability and scope of DTC testing services. Federal regulations require the laboratory to have a "written or electronic request for patient testing from an authorized person," but the regulations do not define "authorized person." Thus it is up to each state to determine who is an authorized person. [13]

Impact of COVID-19

The COVID-19 pandemic fundamentally transformed the diagnostic testing landscape and accelerated trends in the DTC blood testing industry. [15]

Accelerated consumer adoption

The pandemic dramatically increased public awareness of diagnostic testing and normalized at-home health monitoring. Self-testing kits for COVID-19 familiarized millions of consumers with the concept of collecting samples at home, reducing barriers to adoption of other DTC testing services. The blood sample segment dominated the self-testing market with approximately 35.19% revenue share in 2024. [16]

Regulatory flexibility

Emergency regulatory pathways created during the pandemic demonstrated the potential for more flexible oversight frameworks. The FDA's Emergency Use Authorizations for COVID-19 tests expanded point-of-care and over-the-counter testing options, establishing precedents that may influence future regulatory approaches for other diagnostic tests. [15]

Supply chain and operational impacts

The pandemic initially disrupted blood donation and collection services due to lockdowns and social distancing requirements. [17] However, it also spurred innovation in contactless and at-home collection methods, with companies developing low-volume sample collection technologies that require as little as 1 mL of blood compared to traditional testing requiring 50-130 mL. [18]

Telemedicine integration

The rapid expansion of telemedicine during COVID-19 created natural synergies with DTC testing, enabling remote consultation for test result interpretation and follow-up care.

Professional organization positions

Association for Diagnostics and Laboratory Medicine (ADLM)

ADLM (formerly the American Association for Clinical Chemistry) supports expanding and encouraging consumers' ability to access their own health information by allowing individuals to directly order their own laboratory tests. [2] Key positions include: only reputable CLIA-certified laboratories should perform DTC testing; laboratories must validate all sample collection, processing, and testing practices per CLIA regulations; transparent, understandable information must be provided regarding clinical indications, specimen collection, results interpretation, and cost. [1]

American Society for Clinical Pathology (ASCP)

ASCP believes that it is important for physicians and patients to use the test results as a mechanism to discuss a variety of health topics. [2] Key ASCP recommendations include: laboratories should follow applicable state laws regarding direct access testing; laboratories should inform patients about restrictions in insurance and medical coverage; patients should consult with their primary care physician whenever possible after receiving DAT test results. [3]

American Hospital Association (AHA)

The American Hospital Association has expressed concern that FDA's proposal to classify LDTs as medical devices exceeds the agency's appropriate regulatory scope, urging the FDA to continue to apply its enforcement discretion to hospital and health system LDTs and defer regulation of these tests mainly to CMS's strict CLIA oversight, the CAP accreditation and state law. [19] The organization has called on Congress to either exclude hospitals and health systems from this device classification framework or to modernize LDT oversight in a way that promotes innovation while maintaining test accessibility, safety, and effectiveness. [19]

Benefits and concerns

Potential benefits

Potential concerns

Market comparison

The following table compares biomarkers and services offered by major DTC blood testing providers as of November 2025. [18]

Biomarker/TestHealthieOne CompleteFunction HealthVitals Vault MaxMito HealthEmpirical HealthSuperpower AdvancedMarek Diagnostics
HEART / CARDIOVASCULAR HEALTH
Apolipoprotein B (ApoB)✓✓Advanced/Max✓✓✓✓
HDL Cholesterol✓✓✓✓✓✓✓
Lipoprotein (a)✓✓Advanced/Max✓✓Add-on: $159Complete: $895
CRP✓✓✓✓✓✓✓
LDL Cholesterol✓✓✓✓✓✓✓
Non-HDL Cholesterol✓✓✓✓✓✓
Total Cholesterol✓✓✓✓✓✓✓
Total Cholesterol / HDL Ratio✓✓✓✓✓
Triglycerides✓✓✓✓✓✓✓
LDL Medium*✓
LDL Particle Number*✓Add-on: $189
LDL Pattern*✓
LDL Peak Size*✓Add-on: $189
LDL Small*✓Add-on: $189
HDL Size*Add-on: $189
HDL Large*✓Add-on: $189
HDL P*Add-on: $189
Large VLDL P*Add-on: $189
VLDL Size*✓
Apolipoprotein A1✓Add-onMax✓
Apolipoprotein B/Apolipoprotein A1✓Add-on✓
Trimethylamine N-Oxide✓Add-onExecutive: $1950
Triglyceride/HDL Ratio✓✓✓✓
Triglyceride/ApoB Ratio✓✓
Non-HDL/Total Cholesterol Ratio✓✓✓✓
Non-HDL/ApoB Ratio✓✓
LDL/HDL Ratio✓✓✓✓✓
LDL-c/ApoB Ratio✓Advanced/Max✓
LDL-c/Cholesterol total✓✓✓
Neutrophil-to-HDL Cholesterol Ratio✓✓
Atherogenic Index✓✓
Atherogenic Coefficient✓✓
Chol/HDL Ratio✓✓
Cholesterol VLDL✓Max✓
Remnant Cholesterol✓
Asymmetric Dimethylarginine✓Add-on: $159
Epinephrine✓
Arginine✓
Arginine/ADMA Ratio✓
Taurine✓
THYROID
Thyroxine (T4)✓✓ (T4 Free)✓ (T4 Free)✓ (T4 Free)✓ (T4 Free)✓ (T4 Free) and T4 Total✓ (T4 Free)
Triiodothyronine (T3)✓✓ (T3 Free)✓ (T3 Uptake)✓ (T3 Free)✓ (T3 Uptake)✓ (T3 Free)
Free T3:Free T4 RatioMax
Thyroglobulin Antibodies (TgAb)✓Add-on: $139Complete: $895
Thyroid Peroxidase Antibodies (TPO)✓Add-on: $139Complete: $895
Thyroid-Stimulating Hormone (TSH)✓✓✓✓✓
TRAb✓
Thiocyanate✓
Cyclic adenosine monophosphate✓
Tyrosine✓
AUTOIMMUNITY / IMMUNE HEALTH
Rheumatoid Factor (RF)✓✓Add-on: $139
Basophils✓✓✓✓✓✓
Eosinophils✓✓✓✓✓✓
Lymphocytes✓✓✓✓✓✓
Monocytes✓✓✓✓✓✓
Neutrophils✓✓✓✓✓✓
White Blood Cell Count✓✓✓✓✓✓✓
ANA Pattern**✓
ANA Screen**✓Add-on: $139
ANA Titer**✓
IgA✓Add-on
IgG✓Add-on
IgM✓Add-on
Ferritin/CRP Ratio✓✓
CRP/Albumin Ratio (CAR)✓✓✓
Lymphocyte-to-Monocyte Ratio (LMR)✓✓✓
Monocyte-to-Lymphocyte Ratio (MLR)✓✓✓
Neutrophil-to-Lymphocyte & Platelet Ratio (NLPR)✓✓✓
Neutrophil-to-Lymphocyte Ratio (NLR)✓✓✓✓
Platelet/Lymphocyte✓✓✓
Platelet-to-WBC Ratio✓✓
Systemic Immune-Inflammation Index (SII)✓✓✓
Systemic Inflammation Response Index (SIRI)✓✓✓
Monocyte-to-HDL Ratio✓✓✓
Erythrocyte Sedimentation Rate (ESR)✓✓✓
Eosinophils %✓✓✓✓✓
Neutrophils %✓✓✓✓✓✓
Basophils %✓✓✓✓✓
Lymphocytes %✓✓✓✓✓
Monocytes %✓✓✓✓✓
Band Neutrophils %✓Advanced
Leukocyte Esterase✓Advanced
Immature granulocytes (IG)✓✓
Immature granulocytes % (IG%)✓✓
Histamine✓
BLOOD HEALTH
ABO Group and Rhesus (Rh) Factor✓
Hematocrit✓✓✓✓✓✓✓
Hemoglobin✓✓✓✓✓✓✓
MCH✓✓✓✓✓✓✓
MCHC✓✓✓✓✓✓✓
MCV✓✓✓✓✓✓✓
MPV✓✓✓✓✓
Platelet Count✓✓✓✓✓✓✓
Red Blood Cell Count✓✓✓✓✓✓✓
Nucleated RBC✓✓
Promyelocytes✓
Myelocytes✓
Metamyelocytes✓
Blast✓
RDW/MCV✓✓
Reticulocytes %✓
RDW-CV✓✓✓✓✓✓✓
Red Cell Distribution Width-SD (RDW-SD)✓
Reticulocytes✓Complete: $895
IRF✓
RET-He✓
FEMALE / MALE HEALTH
DHEA-Sulfate✓✓Advanced/Max✓✓✓
Estradiol✓✓Advanced/Max✓✓✓
Testosterone✓✓Advanced/Max✓✓✓
Testosterone/CRP Ratio✓✓
Testosterone/Estradiol (T:E2)✓Advanced/Max✓
Testosterone/ApoB Ratio✓✓
Free Testosterone✓Advanced/Max✓✓✓
Free Testosterone:Cortisol ratio✓
% Testosterone FreeAdvanced/Max✓Executive: $1950
Testosterone BioavailableAdvanced/Max✓
% Testosterone BioavailableAdvanced/Max✓
Anti-Mullerian Hormone✓Add-on: $159Complete: $895
FSH✓✓✓Add-on: $189✓
LH✓✓✓Add-on: $189✓
Pregnancy (hCG)Add-on✓
Prolactin✓✓Add-on: $189✓
SHBG✓✓✓✓✓
Free Androgen Index (FAI)✓
PSA✓Max✓Add-on: $189✓
IGF-1✓Add-onMax✓Add-on: $189✓
Androstenedione✓Add-on
Dehydroepiandrosterone✓Add-on: $150
DHT✓Add-on
Androsterone✓
17-Hydroxypregnenolone✓
17-Hydroxyprogesterone✓Add-on: $159Complete: $895
Pregnenolone✓Complete: $895
Progesterone✓Max✓Add-on: $189✓
Estriol✓
Estrone✓
METABOLIC / GLUCOSE & ENERGY
Glucose✓✓✓✓✓✓✓
Hemoglobin A1c (HbA1c)✓✓✓✓✓✓✓
Uric Acid✓✓✓✓✓Complete: $895
Uric Acid / HDL-C✓✓
Insulin✓Advanced/Max✓Add-on: $189✓
Leptin✓Add-on: $129
Glycation Gap✓
LDHMax✓
Insulin Resistance Screening✓✓✓
TyG-BMI Index✓✓
METS-IR✓
eAG (mg/dl)
eAG (mmol/L)
HOMA2-%B✓
HOMA2-%S✓
HOMA2-IR✓✓
QUICKIAdvanced/Max
Galactose✓
Citric acid✓
Malic acid✓
Succinic acid✓
2-Ketoglutaric acid✓
2-Hydroxyglutarate✓
Cis-Aconitic acid✓
AMP✓
ADP✓
GMP✓
GDP✓
Glucose-6-phosphate✓
Pyruvate✓
1,5-Anhydroglucitol✓
Alanine✓
Lactate✓
Adenine✓
Aspartate✓
Dimethylglycine✓
Guanosine✓
Uridine✓
Uridine diphosphate✓
Fumaric acid✓
NUTRIENTS / VITAMINS & MINERALS
Arachidonic Acid/EPA Ratio✓✓✓
Calcium✓✓✓✓✓✓
Ferritin✓✓✓✓✓✓✓
Homocysteine✓✓Advanced/Max✓Add-on: $169Complete: $895
Iron✓✓✓✓✓✓✓
Iron % Saturation✓✓✓✓✓✓✓
Iron Binding Capacity✓✓✓✓✓✓✓
Magnesium✓✓Advanced/Max✓Add-on: $159Complete: $895
Methylmalonic Acid✓Add-onAdd-on: $169
Omega-3: DHA✓✓
Omega-3: DPA✓✓
Omega-3: EPA✓✓
Omega-6 / Omega-3 Ratio✓
Omega-6 Total✓
Omega-3 Total✓
Omega-6: Arachidonic Acid✓✓
Omega-6: Linoleic Acid✓✓
Vitamin D✓✓✓✓✓✓✓
Zinc✓✓Executive: $1950
Vitamin B12✓Add-onAdvanced/Max✓✓Add-on: $169Complete: $895
Corrected Calcium✓Advanced/Max✓✓
Ferritin-to-Albumin Ratio (FAR)✓Advanced/Max✓
Oleic acid✓
Capric acid✓
Gamma-Linolenic Acid✓
Homo-Gamma-Linolenic acid✓
Vaccenic Acid✓
Glutarylcarnitine✓
Propionylcarnitine✓
Docosanoic Acid✓
Octanoic acid✓
Carnitine✓
Choline✓
Vitamin A✓Add-onAdd-on: $159
Vitamin B1✓
Vitamin B2✓Add-on: $169
Vitamin B5✓
Vitamin E✓Add-on: $159
Ascorbic acid✓Add-on: $159
Folate✓Add-onAdvanced/Max✓✓Add-on: $169Complete: $895
Nicotinic acid (Vitamin B3)✓
5-Methyltetrahydrofolate✓
Vitamin K1✓Add-on: $159
Vitamin B6✓Add-on: $169
Biotin✓
Nicotinamide✓
Phosphorus✓
Pyridoxal-5'-phosphate✓
Transferrin✓✓
UIBC✓✓✓
Creatine✓
HEAVY METALS
Lead✓
Mercury✓✓
STRESS / AGING / LONGEVITY
Cortisol✓✓Max✓✓✓
Cortisol:DHEA-S Ratio✓Advanced/Max✓
Corticosterone✓
Cortisone✓
11-Deoxycortisol✓
21-Deoxycortisol✓
Guanine✓
Metanephrine✓
Deoxyinosine✓
Kynurenine✓
Tryptophan✓
LIVER & PANCREAS HEALTH
ALT✓✓✓✓✓✓✓
Albumin✓✓✓✓✓✓✓
Albumin / Globulin Ratio✓✓✓✓✓✓
ALP✓✓✓✓✓✓✓
AST✓✓✓✓✓✓✓
GGT✓✓Advanced/Max✓✓✓
Globulin✓✓✓✓✓✓
Total Bilirubin✓✓✓✓✓✓✓
Bilirubin, Direct✓✓
Bilirubin, Indirect✓✓
FIB-4✓✓
I/D Bilirubin RatioMax✓
Total Protein✓✓✓✓✓✓✓
Amylase✓✓Max✓✓
Lipase✓✓Max✓Executive: $1950
GGT/HDL Ratio✓Advanced/Max✓
BAR✓✓✓
AST:ALT Ratio✓✓✓
Chenodeoxycholic acid✓
Cholic acid✓
Deoxycholic acid✓
Glycochenodeoxycholic acid✓
Glycocholic acid✓
Glycodeoxycholic acid✓
Glycolithocholic acid✓
Glycoursodeoxycholic acid✓
Lithocholic acid✓
Taurochenodeoxycholic acid✓
Taurocholic acid✓
Taurodeoxycholic acid✓
Taurolithocholic acid✓
Tauroursodeoxycholic acid✓
Ursodeoxycholic acid✓
Aminolevulinic acid✓
Coproporphyrin I✓
Coproporphyrin III✓
Protoporphyrin IX✓
Glycerol
KIDNEY HEALTH
Blood Urea Nitrogen✓✓✓✓✓✓✓
BUN / Creatinine Ratio✓✓✓✓✓✓✓
Chloride✓✓✓✓✓✓✓
Creatinine✓✓✓✓✓✓✓
eGFR✓✓✓✓✓✓
Potassium***✓✓✓✓✓✓
Sodium***✓✓✓✓✓✓
Carbon Dioxide***✓✓✓✓✓✓
Anion Gap***✓
Serum Osmolality✓
Sodium:Potassium Ratio✓
Cystatin-CComplete: $895
Xanthine✓
Guanidinoacetate✓
Cystine✓
CK✓✓✓
Hippuric acid✓
NEUROLOGICAL HEALTH
Serotonin✓
GABA✓
Norepinephrine✓
Melatonin✓
3-O-Methyldopa✓
N-Acetylaspartic acid✓
N-Acetylaspartylglutamic acid✓
Kynurenic acid✓
Phosphoserine✓
Nicotinic acid✓
Pipecolic Acid✓
DOPA✓
ANTIOXIDANT LEVELS
1-Methylhistidine✓
Anserine✓
Cystathionine✓
Carnosine✓
Methionine✓
Cysteine✓
Indole-3-propionate✓
Glutathione reduced✓
KETONE BODIES
Beta-Hydroxybutyrate✓
Acetoacetate✓
MUSCLE HEALTH
3-Methylhistidine✓
Threonine✓
Alloisoleucine✓
Alpha-Aminoadipic acid✓
Asparagine✓
Valine✓
Serine✓
Sarcosine✓
Proline✓
Citrulline✓
Glutamic acid✓
Glutamine✓
Histidine✓
Isoleucine✓
Ornithine✓
Alpha-Aminobutyric acid✓
Hydroxyproline✓
Lysine✓
Leucine✓
Beta-Aminoisobutyric acid✓
Phosphoethanolamine✓
Glycine✓
CELL & TISSUE HEALTH
Aldosterone✓
Cytidine✓
Cytidine monophosphate✓
Cytidine triphosphate✓
Cytosine✓
Deoxycytidine monophosphate✓
Deoxycytidine triphosphate✓
Deoxyguanosine✓
Deoxythymidine✓
Deoxyuridine✓
Deoxyuridine monophosphate✓
Dihydroorotic acid✓
Dihydrothymine✓
Dihydrouracil✓
Indole-3-acetic acid✓
Inosine monophosphate✓
S-adenosylhomocysteine✓
Thymine✓
Uracil✓
SUMMARY
Total Biomarkers (Base Package)2939689815810277
Annual Price$450$365$399$324Advanced Heart: $399$388Comprehensive: $495
Blood CollectionAt-home: 2 small vialsQuest: 10+ vials (2 visits)QuestQuestQuestQuestLabCorp
Volume Blood Required1 ml50-130 mL50-130 mL50-130 mL50-130 mL50-130 mL50-130 mL
Follow-upAbnormal markers retestedGeneric fixed testsAbnormal markers retested
ConsultationOn-demand 1:145 min45 min45 min: $100
Turnaround Time3-7 daysSeveral weeks7 days7-14 days7-14 days7-14 days14 days
Proprietary Testing TechnologiesYesNoNoNoNoNoNo
Insurance ReimbursementYesNoNoNoNoNoNo
Medicare ApprovedYesNoNoNoNoNoNo

See also

References

  1. 1 2 3 4 5 6 "Direct Access Testing (DAT) and the Clinical Laboratory Improvement Amendments" (PDF). Centers for Medicare & Medicaid Services. March 2019.
  2. 1 2 3 4 5 6 7 8 "Direct-to-Consumer Laboratory Testing". Association for Diagnostics and Laboratory Medicine. 2024.
  3. 1 2 3 4 "Policies of US Companies Offering Direct-to-Consumer Laboratory Tests". JAMA Internal Medicine. 183 (11): 1185–1193. 2023. doi:10.1001/jamainternmed.2023.4737.
  4. 1 2 3 "Blood Testing Market Size and Share Report, 2030". Grand View Research.
  5. 1 2 "Blood Testing Market Size To Reach $160.50 Billion By 2030". Grand View Research.
  6. ↑ "Global Blood Testing Market Report, 2034". Zion Market Research. May 2025.
  7. 1 2 "Regulatory Knowledge Guide for Laboratory Developed Tests" (PDF). National Institutes of Health. April 2024.
  8. 1 2 3 "Clinical Laboratory Improvement Amendments (CLIA)". U.S. Food and Drug Administration.
  9. ↑ "LDTs: FDA Rolls Out a Phased Implementation for New Regulatory Requirements". Foley & Lardner LLP. May 20, 2024.
  10. ↑ "Unpacking FDA's Final Rule to Regulate Laboratory Developed Testing Services as Medical Devices". Covington & Burling LLP. May 2024.
  11. ↑ "FDA Intends To Regulate Many Clinical Labs as Medical Device Manufacturers". Arnold & Porter. May 2024.
  12. 1 2 "Federal Court Blocks FDA's Final Rule on LDTs: Key Considerations for Clinical Labs". Morgan Lewis. April 21, 2025.
  13. 1 2 "Survey of Direct-to-Consumer Testing Statutes and Regulations" (PDF). Georgetown University, Genetics and Public Policy Center.
  14. 1 2 "Patient Direct Access to Medical Test Results". Connecticut General Assembly. 2008.
  15. 1 2 "COVID-19 Impact on Diagnostic Innovations: Emerging Trends and Implications". PMC. 2021.
  16. ↑ "Self-testing Market Size and Share Report, 2030". Grand View Research.
  17. ↑ "Blood Screening Market Size, Trends Report 2034". Business Research Insights.
  18. 1 2 "Comparing Direct-to-Consumer Health Testing Services". HealthTestReview.
  19. 1 2 "AHA Responds to FDA's Proposed Regulation of Diagnostic Tests". American Hospital Association. April 2024.
  20. ↑ "2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol". Circulation. 139 (25): e1082 –e1143. 2019.
  21. ↑ "ESC/EAS Guidelines for the management of dyslipidaemias". European Heart Journal. 41 (1): 111–188. 2020.
  22. ↑ "Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists". Journal of Clinical Lipidology. 5 (5): 338–367. 2011.
  23. ↑ "Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing". Arthritis & Rheumatism. 47 (4): 434–444. 2002.
  24. ↑ "Range of antinuclear antibodies in healthy individuals". Arthritis & Rheumatism. 40 (9): 1601–1611. 1997.
  25. ↑ "Prevalence and sociodemographic correlates of antinuclear antibodies in the United States". Arthritis & Rheumatism. 64 (7): 2319–2327. 2012.
  26. ↑ "The clinical utility of a positive antinuclear antibody test result". American Journal of Medicine. 126 (4): 342–348. 2013.
  27. ↑ "Diagnostic accuracy for lupus and other systemic autoimmune diseases in the community setting". Archives of Internal Medicine. 164 (22): 2435–2441. 2004.
  28. ↑ "Comparative analysis of paired capillary and venous samples across multiple biomarkers". American Journal of Clinical Pathology. 2021.
  29. ↑ "Study of participants comparing capillary vs. venous blood across chemistry analytes". Clinical Chemistry and Laboratory Medicine. 2024.
  30. ↑ "Validation of miniaturized assays for capillary specimens". Journal of Applied Laboratory Medicine. 2025.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.